Rhoel Dinglasan,
Professor
On This Page
About Rhoel Dinglasan
Accomplishments
-
Advisory Board/Steering Committee – Emerging Infectious Diseases
United States Military Infectious Diseases Research Program
-
Editorial Board
PLoS Neglected Tropical Diseases
-
Director
CDC Southeastern Regional Center of Excellence in Vector Borne Diseases: Gateway Program, The University of Florida
-
Faculty
Developing Excellence in Leadership and Genetic Training for Malaria Elimination in Sub-Saharan Africa (DELTAS) Training Program, Wellcome Trust, UK
-
Young Investigators Award
Human Frontiers Science Program (Strasbourg, France)
Teaching Profile
Courses Taught
-
VME6934 – Topics in Veterinary Medical Sciences
College of Veterinary Medicine
-
VME4906 – Problems in Veterinary Science
College of Veterinary Medicine
-
VME6937L – VMS Graduate Seminar Series
College of Veterinary Medicine
-
VME6905 – Problems in Veterinary Medical Sciences
College of Veterinary Medicine
-
PHC7979 – Advanced Research
College of Public Health and Health Professions
-
GMS7979 – Advanced Research
College of Medicine
-
HSC4913 – Supervised Research Experience
College of Public Health and Health Professions
-
GMS6691 – Special Topics in Cell Biology and Anatomy
College of Medicine
-
VME6933 – Seminar in Infectious Diseases and Experimental Pathology
College of Veterinary Medicine
-
VME6971 – Research for Master’s Thesis
College of Veterinary Medicine
Research Profile
Much of Dr. Dinglasan’s research has focused on finding a vaccine that will prevent malaria transmission. As part of this effort, Dinglasan has focused specifically on ways in which interactions between the human malaria parasites Plasmodium falciparum and P. vivax and the Anopheles mosquito midgut can be better understood to disrupt the transmission of these pathogens to humans. To better study these interactions, he is interested in the application of mass spectrometry toward the molecular and cellular analysis of critical transition steps during malaria parasite transmission. He has also studied how nanoparticle technology can contribute to the development of vaccine and drug delivery systems.
His interest in preventing the spread of malaria has led him to study the developmental biology of the malaria parasite – concentrating on the parasite’s sexual stage. This stage of the parasite’s life cycle does not actually cause disease in humans, so it has not been studied as thoroughly as the erythrocytic stages, where the parasite infects red blood cells and causes disease.
Dinglasan’s lab also has an interest in both supplementing and innovating the current arsenal of anti-malarial treatments. By investigating pathways of infection and disease development, his team hopes to find natural product compounds with potential as drug scaffolds for new anti-malaria drugs. Dinglasan’s lab hopes to preempt eventual drug resistance by focusing on novel biochemical pathways in the parasite that can be targeted by natural product compounds. Combining these approaches allows the lab to target multiple aspects of the pathway from transmission to disease.
Publications
Academic Articles
Grants
Education
-
Doctor of Philosophy in Microbiology & Immunology
University of Maryland School of Medicine
-
Master of Philosophy in Vector Biology
Yale University
-
Master of Public Health in Infectious Disease Epidemiology/Global Health
Yale University
Contact Details
- Business:
- (352) 294-8448
- Business:
- rdinglasan@epi.ufl.edu
- Business Mailing:
-
2055 MOWRY RD RM 375
EMERGING PATHOGENS INSTITUTE
GAINESVILLE FL 32611-2079 - Business Street:
-
2055 MOWRY RD RM 375
GAINESVILLE MD 32611